First experience of ribavirin postexposure prophylaxis for Nipah virus, tried during the 2018 outbreak in Kerala, India

J Infect. 2019 Jun;78(6):491-503. doi: 10.1016/j.jinf.2019.03.005. Epub 2019 Mar 6.

Authors

Sayantan Banerjee¹, Vettakkara Kandy Muhammed Niyas¹, Manish Soneja², Areekkare Purayil Shibeesh³, Muhammed Basheer³, Rajeev Sadanandan⁴, Naveet Wig², Ashutosh Biswas⁵

Affiliations

¹ Infectious Diseases, All India Institute of Medical Sciences, New Delhi, India.
² Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
³ Taluk Hospital, Balussery, Kozhikode, Kerala, India.
⁴ Department of Health and Family Welfare, Government of Kerala, India.
⁵ Department of Medicine, All India Institute of Medical Sciences, New Delhi, India. Electronic address: asuaiims@gmail.com.

PMID: 30851290
DOI: 10.1016/j.jinf.2019.03.005

No abstract available

Publication types

Letter
Comment

MeSH terms

Consensus
Disease Outbreaks
India
Nipah Virus*
Personal Protective Equipment
Ribavirin

Substances

Ribavirin